^ Average Resolution time is the sum total of time taken to resolve each complaint
in days, in the current month divided by total number of complaints resolved in the current month.
Trend of Monthly Disposal of Complaints
Sr. No.
Month
Carried forward from previous month
Received
Resolved*
Pending#
1
Jun, 2026
0
0
0
0
2
Jul, 2026
0
0
0
0
3
Aug, 2026
0
0
0
0
Grand Total
0
0
0
0
*Inclusive of complaints of previous months resolved in the current month.
#Inclusive of complaints pending as on the last day of the month.
Trend of Annual Disposal of Complaints
Sr. No.
Fin. Year
Carried forward from previous year
Received
Resolved*
Pending#
1
2022-23
0
1
1
0
2
2023-24
0
0
0
0
3
2024-25
0
0
0
0
4
2025-26
0
1
1
0
Grand Total
0
2
2
0
*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.
Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL)’.
The above information is a part of company’s filings submitted to BSE.
